Finance

Lists
PAMG:IDX
Bima Sakti Pertiwi Tbk PT
IDR 40.00
0.00%
(0.00) 1D
Nov 11, 3:44:19 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for PAMG...
Open
IDR 40
High
IDR 40
Low
IDR 38
Mkt. cap
125.00B
Avg. vol.
5.56M
Volume
639.70K
52-wk high
IDR 101
52-wk low
IDR 37
EPS
-IDR 1
Shares outstanding
3.12B
No. of employees
71
Open
IDR 40
High
IDR 40
Low
IDR 38
Mkt. cap
125.00B
Avg. vol.
5.56M
Volume
639.70K
52-wk high
IDR 101
52-wk low
IDR 37
EPS
-IDR 1
Shares outstanding
3.12B
No. of employees
71
News stories
From web sources and news partners
About Bima Sakti Pertiwi Tbk PT
CEO-
Employees71
Founded1980
Headquarters-
SectorReal Estate
IndustryProperty management
Websitebimasaktipertiwi.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
12.07B
11.40B
11.30B
10.99B
Cost of goods sold
6.37B
6.66B
6.63B
6.07B
Cost of revenue
6.37B
6.66B
6.63B
6.07B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.48B
2.46B
2.66B
2.06B
Operating expense
3.48B
2.46B
2.66B
2.51B
Total operating expenses
9.86B
9.12B
9.29B
8.58B
Operating income
2.22B
2.28B
2.01B
2.41B
Other non operating income
1.05B
170.99M
-803.95M
891.89M
EBT including unusual items
1.04B
533.68M
-204.95M
-52.86M
EBT excluding unusual items
1.04B
533.68M
-204.95M
-52.86M
Income tax expense
1.02B
920.14M
953.38M
963.31M
Effective tax rate
98.77%
172.41%
-465.18%
-1,822.43%
Other operating expenses
-
-
-
452.82M
Net income
12.79M
-386.46M
-1.16B
-1.02B
Net profit margin
0.11%
-3.39%
-10.25%
-9.24%
Earnings per share
-
-
-
-
Interest and investment income
2.64M
1.93M
3.56M
6.31M
Interest expense
-2.24B
-1.92B
-1.43B
-3.37B
Net interest expenses
-2.24B
-1.92B
-1.43B
-3.36B
Depreciation and amortization charges
-
-
-
-
EBITDA
2.52B
2.41B
2.13B
2.53B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps